CN
Context Therapeutics Inc.
CNTX · NASDAQ
$0.36 +0.03% (+$0.00)
1M -33.81%
Market Cap $33.5M
P/E Ratio -
Div. Yield -
ROE 82.06%
Bulios Fair Price
$0.31
14.9% downside
Current Price
$0.36
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CNTX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.88x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 20.27%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 126.84%
Asset turnover 0.00x
ROE 82.06%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 5.81x
Int. coverage N/A
Stability
15 /100
Unstable Beta 1.69x
Profitable years 0
EPS volatility 65.77%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CNTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin A. Lehr
Employees
15
Headquarters
Philadelphia
Upcoming events
04 NOV
Earnings
Upcoming earnings report